ORGANIZATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative) - USD ($)	3 Months Ended				6 Months Ended		12 Months Ended
	Jun. 30, 2024	Mar. 31, 2024	Jun. 30, 2023	Mar. 31, 2023	Jun. 30, 2024	Jun. 30, 2023	Dec. 31, 2023
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Working capital deficit	$ 3,656,051				$ 3,656,051
Accumulated deficit	11,183,486				11,183,486		$ 10,797,216
Cash	16,648				16,648		36,466
Short term note payable	2,689,575				2,689,575
Deferred tax liability	320,329				320,329
Net loss	124,010	$ 262,260	$ 325,102	$ 466,675	386,270	$ 791,777
Net cash used in operating activity					109,818	390,623
Net revenue					111,000	111,000
Increase in net revenue					32,000	143,000
Liquidation sale					80,000
Net loss					386,000	792,000
Cash used in operating activities					109,000	390,000
Inventory	0				0		133,775
Goodwill	1,936,020				1,936,020
Impairment charge					0	0
Amortization of Debt Issuance Costs and Discounts					840	15,500
Accrued warranty liability					0		$ 1,288
Selling and Marketing Expense	$ 7,812		$ 37,631		17,403	56,412
Product development expenses					1,903	51,339
Stock-based compensation expense					$ 0	$ 0
Share-Based Payment Arrangement, Option [Member]
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Total number of potentially dilutive common stock					408,288	608,288
Warrant [Member]
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Total number of potentially dilutive common stock					199,733	199,733
Preferred B-1 Stock [Member]
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Total number of potentially dilutive common stock					15,000	15,000
Common Stocks [Member]
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Total number of potentially dilutive common stock					999,900	999,900